We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-7.05%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$533M
AUM Growth
+$30.6M
Cap. Flow
+$69.5M
Cap. Flow %
13.05%
Top 10 Hldgs %
65.84%
Holding
49
New
9
Increased
10
Reduced
14
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 30.47%
2 Communication Services 18.1%
3 Real Estate 13.17%
4 Technology 12.06%
5 Energy 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
1
People Inc
PPLI
$3.1B
$66.8M 12.53%
1,737,075
+2,438
+0.1% +$101K
PAR icon
2
PAR Technology
PAR
$637M
$45.9M 8.62%
975,000
-271,885
-22% -$12M
QDEL icon
3
QuidelOrtho
QDEL
$1.09B
$37M 6.95%
+1,115,000
New +$45.6M
SOLV icon
4
Solventum
SOLV
$13.5B
$37M 6.95%
+700,000
New +$42.5M
VTOL icon
5
Bristow Group
VTOL
$1.35B
$36.2M 6.8%
1,079,650
+5,650
+0.5% +$175K
AIV
6
Aimco
AIV
$380M
$31.2M 5.87%
3,769,425
+769,425
+26% +$6.2M
CCOI icon
7
Cogent Communications
CCOI
$594M
$29.6M 5.56%
525,000
+150,000
+40% +$8.95M
BV icon
8
BrightView Holdings
BV
$1.31B
$23.3M 4.37%
+1,750,000
New +$22.3M
OFIX icon
9
Orthofix Medical
OFIX
$455M
$22.1M 4.15%
1,667,688
+396,215
+31% +$5.43M
SPB icon
10
Spectrum Brands
SPB
$2.04B
$21.5M 4.03%
249,937
CIO
11
DELISTED
City Office REIT
CIO
$19.1M 3.59%
3,838,000
TBPH icon
12
Theravance Biopharma
TBPH
$874M
$18M 3.38%
2,124,703
+480,773
+29% +$4.34M
CLFD icon
13
Clearfield
CLFD
$421M
$16.1M 3.02%
417,572
+17,572
+4% +$611K
CNNE icon
14
Cannae Holdings
CNNE
$647M
$14.2M 2.66%
782,350
-1,332,650
-63% -$25.9M
LKFT
15
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$12.4M 2.33%
500,000
+134,000
+37% +$3.8M
SHC icon
16
Sotera Health
SHC
$4.95B
$11.3M 2.12%
+950,000
New +$10.8M
FSP
17
Franklin Street Properties
FSP
$44.8M
$10.9M 2.05%
+7,150,000
New +$13.5M
MBI icon
18
MBIA
MBI
$288M
$10.3M 1.93%
1,875,000
BVFL icon
19
BV Financial
BVFL
$177M
$9.84M 1.85%
826,445
-45,000
-5% -$486K
TSVT
20
DELISTED
2seventy bio
TSVT
$9.57M 1.8%
+2,485,000
New +$11.2M
NODK icon
21
NI Holdings
NODK
$325M
$9.26M 1.74%
605,499
+391
+0.1% +$5.92K
STHO icon
22
Star Holdings Shares of Beneficial Interest
STHO
$112M
$5.66M 1.06%
469,718
-7,754
-2% -$97.2K
PCG icon
23
PG&E
PCG
$47.8B
$4.7M 0.88%
268,921
FBTC icon
24
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.9B
$4.56M 0.86%
87,000
EQC
25
DELISTED
Equity Commonwealth
EQC
$3.18M 0.6%
+163,913
New +$3.12M

Similar funds

Newtyn Management's Q2 2024 Portfolio in Review

As of Q2 2024, Newtyn Management held 49 positions worth $533M, up 6.1% from $502M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Newtyn Management deployed $69.5M of net new capital in Q2 2024, opening 9 new positions and adding to 10 existing holdings. Its largest new stake was QuidelOrtho: 1,115,000 shares worth $37M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 22% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Cannae Holdings, an estimated $25.9M trimmed.

  • Newtyn Management's largest Q2 2024 buy was QuidelOrtho: 1,115,000 shares worth $37M.
  • Newtyn Management added most to Cogent Communications in Q2 2024, an estimated $8.95M increase.
  • Newtyn Management's biggest Q2 2024 reduction was Cannae Holdings, cutting an estimated $25.9M.
  • Newtyn Management fully exited Merrimack Pharmaceuticals, Inc. in Q2 2024, selling an estimated $27.7M.
  • Newtyn Management's ten largest holdings make up 66% of its $533M portfolio in Q2 2024.
  • Newtyn Management opened 9 new positions and closed 9 in Q2 2024.
  • Newtyn Management's portfolio value rose 6.1% quarter-over-quarter to $533M.

Based on Newtyn Management's 13F filing for Q2 2024, filed 14 Aug 2024.